Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Drugmakers ramped up their K Street spending this year.
- Simplified Text
-
Drugmakers ramped up K Street spending this year
- Confidence Score
- 0.950
- Claim Maker
- The author
- Context Type
- News Article
- Context Details
-
{ "date": "04\/24\/2024", "topic": "Pharma lobbying", "source": "POLITICO" } - UUID
- a1165f68-5757-4f30-bcf7-5199b9fbfc65
- Vector Index
- ✗ No vector
- Created
- February 15, 2026 at 4:57 PM (6 months ago)
- Last Updated
- February 15, 2026 at 4:57 PM (6 months ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
Completed
News
21
claims
🔥
1 week ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharmaceutical companies increased lobbying spending in the first quarter of 2024. Key issues driving the spending include 340B program reform, supply chain issues, and pharmacy benefit manager regulations. The article also covers Supreme Court arguments on abortion and bird flu fragments in milk.
Similar Claims (5)
Other claims identified as semantically similar to this one.
-
Simplified: Novartis spent 44 percent more on lobbying last quarter than in 20236 months ago
-
Simplified: The industry was working on issues advancing in Congress6 months ago
-
Simplified: The Pharmaceutical Care Management Association increased lobbying spending by 74 percent compared to last year6 months ago
-
Simplified: Negotiations over policy riders ultimately fell apart6 months ago
-
Simplified: Pharmaceuticals led US lobbying spending 1998-mid 2025 exceeding $6.3 billion1 year ago